Ladder Capital CapEx decreased by 88.3% to $743.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 14.8%, from $872.00K to $743.00K. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 14.4% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $350.00K | $1.25M | $2.00M | $751.00K | $3.11M | $1.80M | $1.29M | $626.00K | $870.00K | $1.14M | $1.73M | $1.37M | $458.00K | $3.02M | $1.65M | $872.00K | $635.00K | $479.00K | $6.36M | $743.00K |
| QoQ Change | — | +257.1% | +60.3% | -62.5% | +313.7% | -42.1% | -28.2% | -51.5% | +39.0% | +31.5% | +51.6% | -20.8% | -66.6% | +558.3% | -45.2% | -47.2% | -27.2% | -24.6% | >999% | -88.3% |
| YoY Change | — | — | — | — | +787.7% | +43.9% | -35.5% | -16.6% | -72.0% | -36.4% | +34.2% | +119.3% | -47.4% | +163.5% | -4.8% | -36.5% | +38.6% | -84.1% | +285.0% | -14.8% |
| Segment | Q1 '25 | Q1 '26 |
|---|---|---|
| Real Estate | $900.00K | $700.00K |
| Total | $872.00K | $743.00K |